EGFR signaling has been highlighted directly or indirectly in a spectrum of neurometabolic conditions, for example, metabolic syndrome, diabetes, Alzheimer's disease, cancer, and cardiorespiratory function. The gene discussed is EGFR; the disease is early-onset autosomal dominant Alzheimer disease.